Integrated electrical profiling system for measuring leukocytes activation from whole blood

Patent metadata

Field	Value
Publication number	US-10098581-B2
Application number	US-201515111584-A
Country	US
Kind code	B2
Filing date	Jan 16, 2015
Priority date	Jan 17, 2014
Publication date	Oct 16, 2018
Grant date	Oct 16, 2018

Abstract

A system includes a microfluidic device configured to isolate one or more particles from a mixture, a flow rate matching device configured to match flow rate of the microfluidic device with flow rate of an electrical measurement device configured to measure an electrical property of the isolated particles, and an electrical measurement device configured to measure an electrical property of the isolated particles.

First claim

What is claimed is:

1. A system comprising:
a microfluidic device configured to isolate one or more particles from a mixture;
an electrical measurement device configured to measure an electrical property of the isolated particles; and
a flow rate matching device configured to match flow rate from the microfluidic device to the flow rate of the electrical measurement device configured to measure an electrical property of the isolated particles.

2. The system of claim 1 , wherein the microfluidic device includes at least one spiral channel having a length and a cross-section consisting of a height and a width defining an aspect ratio adapted to isolate particles along portions of the cross-section of the channel based on particle size.

3. The system of claim 2 , wherein the aspect ratio of the channel is in a range of between about 2 and about 10.

4. The system of claim 1 , wherein the microfluidic device includes a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the height of the radially inner side smaller than the height of the radially outer side, at a flow rate that isolates particles along portions of the cross-section of the microchannel based on particle size, wherein larger particles flow along the radially inner side of the microchannel to a first outlet and smaller particles flow along other portions of the microchannel to at least one other outlet, thereby size separating the particles from the mixture.

5. The system of claim 1 , wherein the flow rate matching device configured to match flow rate is a reservoir for the isolated particles, the reservoir having at least one input for the isolated particles, at least one output for the isolated particles, and a continuous flow of the isolated particles into and out of the reservoir.

6. The system of claim 5 , wherein the flow rate of the continuous flow of the isolated particles is in a range of between about 1 ml/min and about 0.0005 ml/min.

7. The system of claim 5 , wherein the reservoir includes an injection loop, an excess flow container, or a buffer input.

8. The system of claim 1 , wherein the electrical property is the iso-dielectric point.

9. The system of claim 8 , wherein the electrical measurement device configured to measure the iso-dielectric point of the isolated particles is an iso-dielectric separation (IDS) device.

10. The system of claim 9 , wherein the IDS device is a double-sided IDS device.

11. The system of claim 8 , wherein the electrical measurement device configured to measure the iso-dielectric point of the isolated particles is an impedance based electrical properties measurement device.

12. The system of claim 8 , wherein the electrical measurement device configured to measure the iso-dielectric point of the isolated particles is a multiple frequency dielectrophoresis device.

13. The system of claim 8 , wherein the electrical measurement device configured to measure the iso-dielectric point of the isolated particles is a differential electronic detector of dielectrophoresis translation.

14. The system of claim 1 , wherein the electrical property is electrical conductivity.

15. The system of claim 1 , wherein the particles are one or more cells.

16. The system of claim 15 , wherein the one or more cells are leukocytes.

17. The system of claim 16 , wherein the leukocytes are neutrophils.

18. The system of claim 1 , wherein the mixture is a biological sample.

19. The system of claim 18 , wherein the biological sample is blood.

20. A system comprising:
a microfluidic device configured to isolate one or more particles from a mixture;
an iso-dielectric separation (IDS) device configured to measure an iso-dielectric point of the isolated particles; and
a reservoir configured to match flow rate from the microfluidic device to the flow rate of the IDS device, the reservoir having at least one input for the isolated particles, at least one output for the isolated particles, and a continuous flow of the isolated particles into and out of the reservoir.

21. A method of detecting an inflammatory condition in an individual in need thereof, the method comprising:
a) introducing a sample from the individual comprising one or more white blood cells into a system, wherein the system comprises
(i) a microfluidic device that isolates the one or more white blood cells from the sample,
(ii) an iso-dielectric separation (IDS) device that measures the iso-dielectric point of a cell (IDS device), and
(iii) a reservoir configured to match flow rate from the microfluidic device to the flow rate of the IDS device,

wherein the white blood cells are isolated from the sample in the microfluidic device, then introduced into the reservoir and maintained in the reservoir under conditions in which the flow rate of the one or more isolated white blood cells is matched to the flow rate of the IDS device, then introduced into the IDS device and maintained under conditions in which the iso-dielectric point (IDP) of the white blood cells is measured, and wherein a greater number of cells in the sample having a shift in IDP compared to a control indicates an inflammatory condition.

22. A method of detecting leukocyte activation, the method comprising:
a) introducing a sample comprising leukocytes into a system, wherein the system comprises
(i) a microfluidic device that isolates one or more leukocytes from the sample,
(ii) an iso-dielectric separation (IDS) device that measures the iso-dielectric point of a leukocyte, and
(iii) a reservoir configured to match flow rate from the microfluidic device to the flow rate of the IDS device,

wherein the leukocytes are isolated from the sample in the microfluidic device, then introduced into the reservoir and maintained in the reservoir under conditions in which the flow rate of the one or more isolated leukocytes is matched to the flow rate of the IDS device, then introduced into the IDS device and maintained under conditions in which the iso-dielectric point (IDP) of the leukocytes is measured, wherein a shift in IDP of the leukocytes compared to a control indicates leukocyte activation.

Assignees

• Massachusetts Inst Technology

Inventors

• Voldman Joel
• Su Hao-Wei
• Prieto Javier Lopez
• Han Jongyoon
• Wu Lidan

Classifications

• A61B5/412 Primary

  Detecting or monitoring sepsis · CPC title

• B01L2200/0652

  Sorting or classification of particles or molecules · CPC title

• A61B5/14546

  for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

• G01N15/1484

  microstructural devices · CPC title

• A61B5/1468

  using chemical or electrochemical methods, e.g. by polarographic means · CPC title